Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Retina > High-resolution optical coherence tomography improves precision in AMD diagnosis
  • Retina

High-resolution optical coherence tomography improves precision in AMD diagnosis

Ophthalmology 360

High-resolution optical coherence tomography (HR-OCT) significantly improves the accuracy and reliability of identifying and classifying atrophic lesions associated with age-related macular degeneration (AMD) when compared to standard resolution OCT, according to a study.

The findings highlight the superiority of HR-OCT in both qualitative and quantitative assessments, particularly in identifying specific atrophic features and measuring associated parameters.

In this prospective, observational, cross-sectional study, 60 patients (60 eyes) diagnosed with AMD, underwent volume OCT scanning using both HR-OCT and standard resolution OCT devices. Trained graders reviewed and graded the scans, pinpointing specific regions of interest for subsequent analysis. The primary focus of the study was on identifying and classifying complete retinal pigment epithelium and outer retinal atrophy (cRORA), incomplete RORA (iRORA), and other non-atrophic AMD features.

The results showcased substantial to perfect agreement among readers for classifying atrophic lesions, with a noteworthy agreement of 0.88 for HR-OCT and 0.82 for standard resolution OCT. Notably, HR-OCT demonstrated higher accuracy in identifying iRORA lesions compared to its standard counterpart.

In the realm of qualitative assessment, HR-OCT outshone standard OCT, particularly in identifying external limiting membrane (ELM) and ellipsoid zone (EZ) disruption, with agreements of 0.95 and 0.94, respectively. Quantitative measurements of features such as hypertransmission defects, retinal pigment epithelium attenuation/disruption, EZ disruption width, and ELM disruption width exhibited excellent inter-reader agreement with HR-OCT (> 0.90 for all features). In contrast, standard OCT showed only moderate agreement (0.51-0.60) for these quantitative features.

Reference
Mahmoudi A, Corradetti G, Emamverdi M, et al. Atrophic Lesions Associated with Age-related Macular Degeneration: High-resolution versus Standard Optical Coherence Tomography. Ophthalmol Retina. 2023;S2468-6530(23)00513-4. doi: 10.1016/j.oret.2023.10.011. Epub ahead of print. PMID: 37871680.

 

This content is independent editorial sponsored by Astellas. Astellas had no input in the development of this content.

Share

Related Content

  • Retina

Greater gains seen after aflibercept 8 mg switch in poorly controlled nAMD

  • Retina

Aflibercept 8 mg shows comparable IOP safety to 2 mg through 96 weeks

  • Retina

Biosimilar aflibercept-ayyh demonstrates favorable real-world safety and efficacy

  • Geographic Atrophy

Geographic atrophy linked to vision loss, higher healthcare costs, and fall risk

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon